AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $682,196 | -18.9% | 9,761 | -16.6% | 0.00% | -50.0% |
| Q2 2023 | $841,265 | +54.6% | 11,707 | +32.7% | 0.00% | +100.0% |
| Q1 2023 | $544,326 | -18.7% | 8,825 | +1.7% | 0.00% | -50.0% |
| Q4 2022 | $669,257 | +27.2% | 8,677 | -26.4% | 0.00% | +100.0% |
| Q3 2022 | $526,000 | +141.3% | 11,785 | +106.9% | 0.00% | – |
| Q2 2022 | $218,000 | -60.5% | 5,696 | -15.9% | 0.00% | -100.0% |
| Q4 2020 | $552,000 | -44.7% | 6,774 | -51.6% | 0.00% | -50.0% |
| Q3 2020 | $998,000 | -31.7% | 14,005 | -21.1% | 0.00% | 0.0% |
| Q2 2020 | $1,461,000 | +16.1% | 17,755 | -17.0% | 0.00% | 0.0% |
| Q1 2020 | $1,258,000 | -56.3% | 21,385 | -23.3% | 0.00% | -33.3% |
| Q4 2019 | $2,880,000 | +627.3% | 27,865 | +42.3% | 0.00% | – |
| Q3 2019 | $396,000 | – | 19,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |